Dr. John Docherty, M.D

NPI: 1700156403
Total Payments
$99,985
2022 Payments
$32,640
Companies
3
Transactions
40

Payment Breakdown by Category

Consulting$95,459 (95.5%)
Travel$4,367 (4.4%)
Food & Beverage$159.14 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $95,459 21 95.5%
Travel and Lodging $4,367 15 4.4%
Food and Beverage $159.14 4 0.2%

Top Paying Companies

Company Total Records Latest Year
Otsuka Pharmaceutical Development & Commercialization, Inc. $95,053 36 $0 (2022)
Merck Sharp & Dohme LLC $4,883 3 $0 (2022)
Neuronetics, Inc. $49.23 1 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2022 $32,640 17 Otsuka Pharmaceutical Development & Commercialization, Inc. ($27,757)
2021 $67,296 22 Otsuka Pharmaceutical Development & Commercialization, Inc. ($67,296)
2020 $49.23 1 Neuronetics, Inc. ($49.23)

All Payment Transactions

40 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/19/2022 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $3,022.50 General
07/25/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $2,040.00 General
06/24/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $2,040.00 General
05/19/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $2,040.00 General
05/06/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $2,040.00 General
03/17/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $2,040.00 General
03/08/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $2,040.00 General
02/07/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $6,528.00 General
01/21/2022 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $1,162.50 General
01/11/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $6,528.00 General
01/11/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Travel and Lodging Cash or cash equivalent $1,781.90 General
01/11/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Travel and Lodging Cash or cash equivalent $588.00 General
01/11/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Food and Beverage Cash or cash equivalent $34.89 General
01/11/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Travel and Lodging Cash or cash equivalent $23.40 General
01/11/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Travel and Lodging Cash or cash equivalent $20.20 General
01/11/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Travel and Lodging Cash or cash equivalent $12.96 General
01/03/2022 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $697.50 General
12/06/2021 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $6,528.00 General
12/06/2021 Otsuka Pharmaceutical Development & Commercialization, Inc. Travel and Lodging Cash or cash equivalent $411.62 General
12/06/2021 Otsuka Pharmaceutical Development & Commercialization, Inc. Travel and Lodging Cash or cash equivalent $280.58 General
12/06/2021 Otsuka Pharmaceutical Development & Commercialization, Inc. Travel and Lodging Cash or cash equivalent $280.58 General
12/06/2021 Otsuka Pharmaceutical Development & Commercialization, Inc. Food and Beverage Cash or cash equivalent $32.52 General
12/06/2021 Otsuka Pharmaceutical Development & Commercialization, Inc. Travel and Lodging Cash or cash equivalent $17.99 General
12/06/2021 Otsuka Pharmaceutical Development & Commercialization, Inc. Travel and Lodging Cash or cash equivalent $8.82 General
11/19/2021 Otsuka Pharmaceutical Development & Commercialization, Inc. Food and Beverage Cash or cash equivalent $42.50 General

About Dr. John Docherty, M.D

Dr. John Docherty, M.D is a Neurology healthcare provider based in White Plains, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2012. The National Provider Identifier (NPI) number assigned to this provider is 1700156403.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Docherty, M.D has received a total of $99,985 in payments from pharmaceutical and medical device companies, with $32,640 received in 2022. These payments were reported across 40 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($95,459).

Practice Information

  • Specialty Neurology
  • Other Specialties Psychiatry
  • Location White Plains, NY
  • Active Since 01/11/2012
  • Last Updated 03/07/2023
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1700156403

Products in Payments

  • NEUROSTAR TMS THERAPY (Device) $49.23

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in White Plains